Further upstream regulators are mainly linked to the inflammatory response and cytokine signaling, such as CCR2, TNF, etc. Such findings indicate the necessity to conduct more than two therapeutic cycles with the combined therapy in order to also kill surviving tumor cells. The gene discussed is CCR2; the disease is neoplasm.